Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

A coiling protein “shell,” called a nucleocapsid, shown here, surrounds Ebola’s genetic material, which consists of single-strand RNA. University of Delaware researchers are simulating the way ...

Phosphorylation of the Nucleocapsid Protein The first step in determining which host kinases to use for drug development is determining the phosphorylation sites of the intended target.

A recent paper by Syed et al. demonstrates that mutations in the Nucleocapsid (N) protein, one of the four structural proteins in SARS-CoV-2 in addition to the Spike protein, plays a critical role ...

The researchers also hinted that the diminished anti-nucleocapsid antibody response among the vaccinated could lead to undercounting of breakthrough cases, when measured by antibody sampling.

In a new study, researchers found that nucleocapsid antigen in the blood (antigenemia) is a sensitive and specific biomarker for acute coronavirus disease 2019 infection.

Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure ...

A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that ...

Discovery of nucleocapsid structure paves the way for antivirals against Ebola virus and other filoviruses.

Conclusions The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.